TRCT
EQ icon

Tower Research Capital (TRC)’s Equillium EQ Stock Holding History

Tower Research Capital (TRC)’s Portfolio EQ Stock Details EQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.63K Buy
2,385
+1,094
+85% +$2.62K ﹤0.01% 4119
2026
Q1 		$2.58K Sell
1,291
-2,779
-68% -$4.57K ﹤0.01% 4453
2025
Q4 		$6.31K Sell
4,070
-2,336
-36% -$2.85K ﹤0.01% 4068
2025
Q3 		$9.16K Sell
6,406
-108
-2% -$114 ﹤0.01% 4036
2025
Q2 		$2.05K Sell
6,514
-305
-4% -$122 ﹤0.01% 4709
2025
Q1 		$2.67K Buy
6,819
+856
+14% +$638 ﹤0.01% 4518
2024
Q4 		$4.46K Buy
+5,963
New +$4.93K ﹤0.01% 4458
2024
Q2 		– Sell
-7,359
Closed -$17K – 5758
2024
Q1 		$17K Sell
7,359
-2,023
-22% -$3.52K ﹤0.01% 3143
2023
Q4 		$6.78K Sell
9,382
-510
-5% -$303 ﹤0.01% 4698
2023
Q3 		$7.32K Sell
9,892
-2,627
-21% -$2.11K ﹤0.01% 4480
2023
Q2 		$9.39K Buy
12,519
+9,074
+263% +$6K ﹤0.01% 4293
2023
Q1 		$3K Sell
3,445
-5,919
-63% -$5.66K ﹤0.01% 5186
2022
Q4 		$10K Buy
9,364
+616
+7% +$988 ﹤0.01% 3986
2022
Q3 		$19K Buy
8,748
+4,190
+92% +$10K ﹤0.01% 3973
2022
Q2 		$9K Sell
4,558
-1,036
-19% -$2.6K ﹤0.01% 4551
2022
Q1 		$18K Buy
5,594
+2,118
+61% +$7.75K ﹤0.01% 3621
2021
Q4 		$13K Buy
+3,476
New +$18.8K ﹤0.01% 4167
2021
Q3 		– Sell
-166
Closed -$1K – 5856
2021
Q2 		$1K Sell
166
-2,374
-93% -$15K ﹤0.01% 5198
2021
Q1 		$18K Sell
2,540
-3,968
-61% -$28.5K ﹤0.01% 3960
2020
Q4 		$35K Buy
+6,508
New +$34K ﹤0.01% 3447
2020
Q3 		– Sell
-3,777
Closed -$11K – 4886
2020
Q2 		$11K Sell
3,777
-97
-3% -$276 ﹤0.01% 3965
2020
Q1 		$10K Sell
3,874
-2,217
-36% -$9.54K ﹤0.01% 2017
2019
Q4 		$20K Buy
6,091
+5,834
+2,270% +$21.9K ﹤0.01% 1910
2019
Q3 		$1K Sell
257
-3,396
-93% -$14.6K ﹤0.01% 3846
2019
Q2 		$21K Buy
3,653
+1,236
+51% +$7.77K ﹤0.01% 2146
2019
Q1 		$19K Sell
2,417
-5,751
-70% -$47.4K ﹤0.01% 2292
2018
Q4 		$67K Buy
+8,168
New +$114K ﹤0.01% 1146

Other funds holding EQ

JT
Jupiter Topco New York $245B AUM
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Tower Research Capital (TRC)'s EQ Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Equillium (EQ) stake by 85% in Q2 2026, buying an estimated $2.62K and bringing the position to 2,385 shares worth $7.63K. The position accounts for ﹤0.01% of the portfolio, ranked #4119.

Tower Research Capital (TRC) first reported a position in EQ in Q4 2018 and has held it in 27 quarters since. The position peaked at $67K in Q4 2018. 60 funds tracked by Wall St. Rank hold EQ as of Q2 2026.

  • Tower Research Capital (TRC) held 2,385 shares of Equillium worth $7.63K as of Q2 2026.
  • Tower Research Capital (TRC) bought 1,094 Equillium shares in Q2 2026, an estimated $2.62K.
  • Equillium made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4119 holding.
  • Tower Research Capital (TRC) first reported a position in Equillium in Q4 2018 and has held it in 27 quarters since.
  • Tower Research Capital (TRC)'s Equillium position peaked at $67K in Q4 2018.
  • 60 funds tracked by Wall St. Rank held Equillium as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.